Search hospitals > Iowa > Ames
Mary Greeley Medical Center
Claim this profileAmes, Iowa 50010
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Cancer
209 reported clinical trials
2 medical researchers
Summary
Mary Greeley Medical Center is a medical facility located in Ames, Iowa. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Mary Greeley Medical Center is involved with conducting 209 clinical trials across 349 conditions. There are 2 research doctors associated with this hospital, such as Debra M. Prow and Joseph J. Merchant.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage II
Stage III
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Debra M. ProwMcFarland Clinic PC - Ames6 years of reported clinical research
Expert in Lung Cancer
Expert in Breast Cancer
125 reported clinical trials
185 drugs studied
Joseph J. MerchantMcFarland Clinic - Ames2 years of reported clinical research
Expert in Lung Cancer
Expert in Breast Cancer
100 reported clinical trials
153 drugs studied
Clinical Trials running at Mary Greeley Medical Center
Lung Cancer
Bladder Cancer
Breast Cancer
Kidney Cancer
Pancreatic Cancer
Breast cancer
Melanoma
Ovarian Cancer
Lymphoma
Cutaneous Melanoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mary Greeley Medical Center?
Mary Greeley Medical Center is a medical facility located in Ames, Iowa. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Mary Greeley Medical Center is involved with conducting 209 clinical trials across 349 conditions. There are 2 research doctors associated with this hospital, such as Debra M. Prow and Joseph J. Merchant.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.